Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AL513122.2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | SMIM22 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | AL513122.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ATP8B4 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | NUMBL | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | LOXL2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
mRNA | PTK2B | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | CD101 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | ASB3 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |